Circulomics Inc

Novel Microdevices, Inc., based in Baltimore, MD, is at the forefront of medical diagnostic innovation, specializing in rapid point-of-care testing technologies. Recently awarded a substantial grant from the Maryland Department of Commerce, the company is establishing a GMP-compliant pilot manufacturing facility to produce groundbreaking microfluidic cartridges for its sample-to-answer diagnostic platform. The company's flagship Novel Dx device employs advanced polymerase chain reaction (PCR) techniques to deliver lab-quality results for infectious diseases, including Flu, RSV, and COVID-19, in just 15 minutes. With its portable and battery-powered design, Novel Microdevices aims to enhance healthcare accessibility in low-resource settings and improve patient outcomes through timely diagnosis and treatment. Generated from the website

Flavocure Biotech Inc. is a leading biotechnology company based in Baltimore, MD, specializing in the transformation of natural products into innovative cures for patients. With a focus on oncology, Flavocure has discovered several promising drug candidates that are being advanced through clinical research in collaboration with prestigious research institutions worldwide. Their lead drug candidate, Caflanone, has received FDA Orphan Drug Designation for pancreatic cancer and has shown activity against various cancers, including glioblastoma, acute myeloid leukemia, and multiple myeloma. Driven by a mission to address the urgent need for transformative therapies, Flavocure Biotech is dedicated to developing next-generation solutions inspired by nature. Their research focus areas include pancreatic cancer, glioblastoma, myeloma, and acute myeloid leukemia. With a team of experienced leaders and strategic research collaborations with top academic institutions, Flavocure is actively seeking partnering opportunities with pharmaceutical and biotechnology companies to expand their portfolio and make a significant impact in the field of cancer treatment.Generated from the website

PyroDex is a Baltimore-based company specializing in pyrogen testing systems, offering prompt and reliable findings through their Monocyte Activation Test (MAT) technology. Their comprehensive approach detects various types of contaminants, including endotoxins, molds, yeasts, viruses, and Gram-positive bacteria, ensuring the safety of medical drugs and devices. With their automated MAT technology, PyroDex provides accurate and quantifiable results within a short turnaround time, enabling clients to bring their products to market faster. By utilizing human-sourced monocytes, PyroDex's MAT technology mimics the fever response to contaminants in vivo, offering consistent and quantifiable results that provide statistical confidence among product batches. Their unparalleled comprehensive view of a product's safety status allows for the detection of any contaminant that may cause fever, sepsis, multiple organ failure, or death, regardless of its specific molecular structure. With a focus on safer medical drugs and devices, PyroDex aims to improve treatment and save lives.Generated from the website